Bromo-DragonFLY

Not scheduled at the federal level. The Federal Analogue Act may apply if sold for human consumption due to structural similarities with DOB and 2C-B. Listed as a Schedule I controlled substance in the state of Oklahoma.

Bromo-DragonFLY is covered as a benzodifuran phenethylamine by item 13 of Annex II to Decree No. 560/2019. Article 2 of that decree treats substances within Annex II chemical groups as estupefacientes under Article 77 of the Criminal Code. Law No. 23.737 therefore criminalizes unauthorized production, preparation, distribution, and possession of the substance.

Listed under Schedule 9 of the Poisons Standard nationally since February 2009, making possession, production, and sale illegal. Additionally added to Schedule 2 of the Queensland Drugs Misuse Regulation 1987 as of September 9, 2011.¹¹

Bromo-DragonFLY is covered as a phenethylamine-derived new psychoactive substance under Annex II, item 2, of Austria's Neue-Psychoaktive-Substanzen-Verordnung; the provision expressly covers derivatives bearing benzofuran ring systems. The Neue-Psychoaktive-Substanzen-Gesetz makes it an offence, when done for gain and for human psychoactive use, to produce, import, export, supply, or procure a substance covered by that class, punishable by up to two years' imprisonment.

Canada placed it in Schedule III of the Controlled Drugs and Substances Act effective October 12, 2016, through the broad 2C-phenethylamine entry covering salts, derivatives, isomers, and salts of derivative or isomer forms; that entry applies to compounds with a 2,5-dimethoxyphenethylamine core.¹⁶

Banned on December 3, 2007, following recommendations from the Danish Health Ministry. Classified as a dangerous narcotic substance, prohibiting possession, manufacture, importation, supply, and usage.

Classified as an illegal designer drug as of March 12, 2012. Added to the national list of controlled substances.²⁰

Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) as a derivative of 2-phenethylamine. Production and sale are prohibited; however, possession and import are not penalized when intended solely for personal consumption.

Designated as a controlled substance effective August 19, 2015.

Listed on the Norwegian narcotics list²⁵ and controlled under the 'Derivatbestemmelsen,' an analogue act-type provision that regulates structurally similar compounds.²⁵

Not currently scheduled or controlled under Polish drug legislation.

Bromo-DragonFLY is expressly named in Romania’s current Law 143/2000 Annex Table II, not merely captured by an analogue inference. Articles 1(b)-(c) classify substances in Tables I-II as drugs of high risk; the consolidated ANM text includes the Bromo-dragonfly line and records that the 2010 amendment (OUG No. 6/2010, approved by Law No. 92/2010) is incorporated. For an expressly listed Table II substance, unauthorized operations are prohibited: art. 2(2) covers cultivation, production, manufacture, preparation, offering, sale, distribution, delivery, sending, transport, procurement, purchase, possession and other circulation and provides 5–15 years’ imprisonment plus disqualification from certain rights; art. 3(2) covers unauthorized introduction into/out of Romania and import/export and provides 10–20 years plus disqualification; art. 4(2) covers production or possession for personal consumption and provides 6 months–3 years. Article 22(1) also prohibits consumption of nationally controlled drugs without a prescription. Romania’s Law 194/2011 is a residual framework for products whose legal regime is not otherwise regulated: its ‘substitute’ definition covers an unregulated substance/product capable of psychoactive effects that can replace a narcotic, psychotropic or nationally controlled substance; operations with susceptible products require authorization, and unauthorized operations are penalized under art. 16. Because Bromo-DragonFLY already has an express Law 143 Table II entry, the Law 194 substitute route does not replace or dilute that listing. An unlisted analogue would require a fact-specific Law 194 assessment/authorization process; it is not automatically a Table II substance merely because it is structurally related. The official ANM consolidated PDF states that it includes amendments through Law No. 30/2025 (published 26 March 2025); the official Senate record and promulgated text confirm the later Law No. 172/2024 amendments to Law 194 (published 31 May 2024).

Listed as a Schedule IV narcotic substance as of January 3, 2008, under Medical Products Agency regulation LVFS 2007:14. Previously classified as a 'health hazard' on July 15, 2007, under SFS 2007:600, which prohibited sale, purchase, retail, and possession.

The official Turkish National Drug Report reproduces the 2013/5742 decision, which expressly places Bromo-Dragonfly in the 113-substance annex made subject to Law 2313, so it is not merely an analogue or a generic-NPS inference. The 2024 edition of the official Narkotik report, covering 2023, still identifies Law 2313 as part of Turkey's legal framework and describes the continuing Early Warning System process by which NPS are brought under Law 2313; it records 1,045 NPS brought under the law through 31 December 2023. Under the current Justice Ministry text of TCK art. 188, unauthorized manufacture/import/export of a controlled drug carries 20–30 years' imprisonment and 2,000–20,000 days' judicial fine; domestic sale, offering for sale, giving, dispatch, transport, storage, purchase, acceptance or possession carries at least 10 years' imprisonment and 1,000–20,000 days' judicial fine. TCK art. 191 separately provides 2–5 years' imprisonment for purchase, acceptance, possession or use for personal use, with a five-year postponement of public prosecution and supervised release provisions. Which provision applies to possession is fact-specific. The named scheduling makes Bromo-Dragonfly prohibited and subjects production, supply and importation to the stated penalties.

Bromo-DragonFLY is listed as a controlled psychotropic substance in the United Arab Emirates. The federal drug law identifies the substance by its chemical name and the Bromo-DragonFLY name.

Not explicitly named in the Misuse of Drugs Act 1971. Coverage under the phenylethylamine Class A catch-all clause is disputed due to its benzodifuran structure. Definitively covered by the Psychoactive Substances Act 2016 when sold or traded for human consumption.⁴⁹

The current BetmVV-EDI is dated 13 March 2026; its Annex 6 item 130 is an ellipsis, not a live substance designation. Item 315 instead defines Phenylalkylamine as each substance structurally derived from phenethylamine, unless already in lists a, b, d or f, with the specified alkyl side-chain, phenyl-ring and amino-nitrogen substitution criteria; industrial and scientific use is exempted, but private use is not. PubChem identifies Bromo-DragonFLY as an alpha-methyl phenethylamine or amphetamine-type scaffold bearing bromine and fused furo rings, bringing it within the generic coverage of item 315. The exact name is not separately listed in the current Annex 1 or Annex 6 text; nearby named entries such as Brolamfetamin/DOB, 4-Brom-2,5-dimethoxyamphetamin and 2C-B are distinct substances. Under BetmKV Art. 3(2)(e), Verzeichnis e materials and products are subject to the control measures for Verzeichnis-a narcotics, and Art. 11 requires an operating permit to handle controlled substances. For unauthorized conduct involving a controlled substance, BetmG Art. 19 provides up to three years' imprisonment or a monetary penalty, with a minimum one-year custodial sentence in specified aggravated cases; Art. 19a provides a fine for unauthorized intentional consumption or a personal-use Art. 19 offense, and Art. 19b contains a narrow minor-quantity personal-use rule. Those penalties are conduct- and fact-specific and do not turn the e classification into an unqualified Verzeichnis-d prohibition. Swissmedic's working list is not exhaustive; only the BetmVV-EDI lists are binding.